Cargando…

Insulin degludec aspart: One-year real world experience

BACKGROUND: This retrospective analysis describes the use of insulin degludec aspart (IDegAsp) in India. MATERIAL AND METHODS: All subjects who had received IDegAsp for 52 weeks at two endocrine centers were included in this study. RESULTS: Forty-eight subjects (40 men), with mean age of 54.33 ± 9.6...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Baruah, Manash P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855967/
https://www.ncbi.nlm.nih.gov/pubmed/27186556
http://dx.doi.org/10.4103/2230-8210.177416

Ejemplares similares